What Is The Creatinine Level For Stage 1 Kidney Disease

Stage 1 chronic kidney disease means an eGFR of 90 or above, which is the normal range, plus evidence of kidney damage that has persisted for at least three months. Because filtration is normal, serum creatinine in stage 1 is typically normal too: broadly 0.6 to 1.1 mg/dL in women and 0.7 to 1.3 mg/dL in men, though every laboratory sets its own range. If you are searching for the creatinine number that defines stage 1, there isn’t one. The stage is defined by the damage marker, not by the blood test.

That marker is most often albumin leaking into the urine. It can also be blood in the urine with no other explanation, an abnormality seen on a scan such as polycystic or scarred kidneys, a biopsy finding, an inherited condition, or a history of transplant. Any one of those, present on two occasions three months apart, makes the diagnosis even when every blood result looks textbook. If you want the numbers themselves in context first, what counts as a normal creatinine level sets out the ranges by age and sex, and what creatinine actually is explains where the molecule comes from.

Why there is no creatinine number that defines stage 1

Search results for this question are full of tables that give a creatinine value for each stage. Most of them are wrong, or at least badly misleading, and it is worth being clear about why.

The staging system for chronic kidney disease does not use creatinine directly at all. It uses estimated glomerular filtration rate, or eGFR, which is calculated from creatinine along with age and sex. Creatinine is the raw ingredient; eGFR is the finished number that stages are built on. The relationship between the two is not fixed, because the same creatinine produces a very different eGFR in a 25-year-old man and a 78-year-old woman. A creatinine of 1.1 mg/dL might give an eGFR near 90 in one person and near 55 in another. So a table that assigns creatinine values to stages has to pretend that everyone is the same age and build, which nobody is.

Then there is the specific problem with stage 1. The eGFR cut-off for stage 1 is 90 or above, and that is the normal range. Anyone with completely healthy kidneys also has an eGFR of 90 or above. So the eGFR alone cannot tell you whether someone has stage 1 disease or no disease whatsoever. The distinguishing feature has to come from somewhere else entirely, and that somewhere else is the evidence of damage.

This is not a quirk of the system so much as the whole design intention behind it. When the current framework was written, the aim was to catch kidney disease early enough for it to matter, and by the time creatinine has risen, a large fraction of kidney function has already gone. Waiting for the blood test to move means waiting years. Detecting protein in the urine catches the same disease process much earlier, sometimes a decade earlier, at a point where the trajectory can still be changed.

What stage 1 actually means

The formal definition has three components, and all three have to be satisfied.

Miss any one of these and you do not have stage 1 CKD. Normal eGFR with no damage marker is simply normal kidneys. Damage markers that vanish on repeat testing were acute or artefactual. And an eGFR below 90 with damage would put you in stage 2 or beyond rather than stage 1.

There is a fourth thing worth stating explicitly, because it causes real confusion. A low eGFR without any damage marker is also not automatically CKD in the way people assume, though it is treated differently once it drops far enough. An otherwise healthy 80-year-old with an eGFR of 75 and a completely clean urine test has age-related decline, and whether to label that as disease has been argued about for two decades. Stage 1 sits at the opposite corner of the same argument: damage without any loss of function yet.

Why staging needs two measurements, not one

For years, chronic kidney disease was staged on eGFR alone. Five numbered stages, one axis, and you slotted into whichever band your filtration fell in. It was simple and it was inadequate, because two people with identical eGFRs can have wildly different outcomes depending on how much protein they are leaking.

Take two patients with an eGFR of 55, which is stage 3a. The first has no albumin in the urine at all. The second is losing 400 mg of albumin per gram of creatinine. Over the following decade, the second is at substantially higher risk of progressing to kidney failure, of cardiovascular events, and of dying, even though the number that named their stage is identical. One axis simply could not express that difference.

So the system now runs on two axes. The first is G, for filtration, running G1 through G5. The second is A, for albuminuria, running A1 through A3. Your position is a pair: G1 A2, G3b A1, G2 A3. This is a substantially better predictor of what will actually happen than either measurement alone, and it is the reason stage 1 can exist at all. Without the A axis, a person with normal filtration and heavy protein leak would appear entirely healthy.

The grid: where stage 1 sits

Kidney specialists work from a grid rather than a list. Filtration categories run down the side, albuminuria categories run across the top, and risk increases as you move down and to the right. Stage 1 occupies the top row, and crucially, only part of it.

Read the top row carefully. G1 A1, meaning normal filtration and normal albumin, is not kidney disease at all unless a different marker such as an abnormal scan is present. G1 A2 and G1 A3 are stage 1. Same eGFR, same creatinine, entirely different label, and the only thing separating them is a urine test that many people have never had done.

The colors in the grid are not decorative. They map to measured risk of progression and of cardiovascular events. A person sitting at G1 A3 carries meaningfully higher long-term risk than someone at G3a A1, despite the second person’s filtration being barely more than half the first person’s. Filtration is not the whole story, and at stage 1 it is not the story at all. For how the lower rows work in practice, see creatinine levels in stage 3 kidney disease and stage 4 creatinine levels.

A1, A2 and A3: how the albumin categories work

Albumin is a protein your blood carries in large quantities and your kidneys are supposed to keep hold of. A healthy glomerulus, the tiny filtering unit, has a barrier with a charge and a pore size that turns albumin away. When that barrier is damaged, albumin slips through into the urine. How much slips through is the A category.

The standard test is the urine albumin-to-creatinine ratio, usually written ACR or uACR. You give a urine sample, ideally the first one of the morning, and the laboratory measures both albumin and creatinine in it and divides one by the other. Using the ratio rather than the raw albumin concentration corrects for how dilute or concentrated the sample happens to be, which is why a random sample works and a 24-hour collection is rarely needed now.

Two units are in circulation and mixing them up is a common source of panic. Milligrams per gram is standard in the United States; milligrams per millimole is standard in the UK and much of Europe. The conversion is roughly a factor of nine, so 30 mg/mmol is around 265 mg/g, close enough to the 300 threshold to be treated as the same boundary. If your result looks alarmingly high or reassuringly low, check which unit is printed on the report before drawing any conclusion. Our guide to calculating the albumin-creatinine ratio walks through the arithmetic, and the normal protein-creatinine ratio covers the related test that measures total protein rather than albumin alone.

One practical warning. A single ACR above 30 does not put you in A2 for life. Heavy exercise in the previous 24 hours, a urinary tract infection, a fever, menstruation, marked hyperglycemia and even prolonged standing can all push albumin excretion up temporarily. Good practice is to confirm an abnormal ACR with a repeat early-morning sample, and to confirm it again after three months before the chronic label is applied.

How you can have normal filtration and damaged kidneys at the same time

This is the part that people find hardest to accept, and reasonably so. If the kidneys are damaged, why is the filtration rate normal?

The answer is spare capacity. You are born with something in the order of a million filtering units per kidney, which is far more than you need. People donate a kidney and live normally on one. That redundancy means the kidney can lose a substantial proportion of its filtering units before the total filtration rate drops enough to notice. The remaining glomeruli increase their individual workload to compensate, a process called hyperfiltration, and the overall eGFR holds steady while the underlying situation quietly deteriorates.

In early diabetic kidney disease the compensation goes further still. eGFR can actually rise above normal, sometimes to 130 or 140, at a point when the damage is already established. That is not good news. It is the kidney running hot, and the hyperfiltration itself contributes to the wear that follows. A rising eGFR in someone with diabetes and new albuminuria is a warning sign, not a reassurance, which is one of the more counterintuitive facts in nephrology.

So the two tests are not competing versions of the same information. They look at different properties of the same organ. A perfect creatinine with a leaking filter is a coherent picture, not a contradiction, and it describes stage 1 exactly. This is also why creatinine in urine is measured alongside albumin rather than instead of it, and why the difference between creatinine clearance and GFR matters when interpreting anything at the normal end of the scale.

What creatinine actually looks like in stage 1

Since the question that brought you here is about a number, here is the honest version of the number.

In stage 1, serum creatinine sits inside the reference range for your age, sex and build. Typical adult reference ranges are around 0.6 to 1.1 mg/dL for women and 0.7 to 1.3 mg/dL for men, which converts to roughly 53 to 97 µmol/L and 62 to 115 µmol/L respectively. A muscular man can be at 1.3 and completely normal. A small, elderly woman can be at 0.9 and have significantly reduced filtration, because she produces so little creatinine that even a modest value implies impaired clearance.

Look at the fourth row. Creatinine 0.7, eGFR 101, ACR entirely normal, and still stage 1 chronic kidney disease, because the ultrasound found structural abnormality that has been confirmed to persist. Not one number on the blood panel is abnormal. That is stage 1 in its purest form and it is why a creatinine-based answer to this question cannot work.

Row three is worth a second look too. That creatinine of 1.1 mg/dL is inside the male reference range and would be reported without a flag on most laboratory printouts. The eGFR of 92 is normal. Yet the biopsy shows established glomerular disease and the ACR is over 300. Nothing in the blood work would have found this person. The urine test did.

How stage 1 is usually discovered

Almost nobody is diagnosed with stage 1 because they felt unwell. There are no symptoms at this stage. No swelling, no fatigue attributable to the kidneys, no change in how you pass urine unless the underlying cause produces its own signs. It is found by testing, and the testing is nearly always being done for some other reason.

Notice what is common to all six: none of them started with the patient noticing anything. This is one reason the diagnosis lands so awkwardly. You went in for something routine and came out with a chronic disease label, on the strength of a test you may not have known was being done.

It is also why so much stage 1 disease goes undetected. If you have no diabetes, normal blood pressure and no reason for anyone to check your urine, an ACR is unlikely to be requested. Standard blood panels do not include a urine albumin test. You can have stage 1 CKD for years while every blood test you have taken comes back clean, which for most people is not a disaster, but is worth knowing.

The damage markers that qualify

Not just any abnormality counts. The recognized list is specific, and understanding which one applies to you is more useful than the stage number itself, because the marker points to the cause and the cause determines what happens next.

Some of these are far more consequential than others. Biopsy-proven active glomerulonephritis at G1 A3 is a serious diagnosis that needs specialist care, even though the creatinine is normal. A single small kidney found incidentally in a 50-year-old, with normal albumin and normal filtration, technically meets the criteria and will very likely never cause a problem. Both are labeled stage 1. The label flattens a genuine difference, which is worth remembering before reading too much into it.

This is the strongest argument for asking your doctor a specific question: not what stage am I, but what is the marker and what is the cause? Two people with the same stage can need completely different follow-up. The NIDDK summary of CKD tests and diagnosis sets out how the pieces are meant to fit together.

Why albuminuria matters far more than most people are told

When albumin turns up in the urine it is often presented as a minor abnormality to keep an eye on. That undersells it substantially, in two directions.

First, as an early signal. The filtration barrier leaking protein is direct physical evidence that the glomerulus is damaged. It is not an inference or a calculation; it is the thing itself. That gives it a sensitivity that creatinine cannot match. In diabetes, albuminuria commonly appears years before eGFR moves at all, which is the entire rationale for annual screening.

Second, as a predictor. Albuminuria independently predicts progression to kidney failure, cardiovascular events and death, and it does so across the whole range of filtration rates. Higher albumin means higher risk at every eGFR. In large population studies the relationship holds even below the A2 threshold, so someone with an ACR of 20 carries slightly more risk than someone with an ACR of 5, despite both being labeled A1. The line at 30 is a useful convention rather than a biological cliff.

There is a genuinely encouraging side to this too. Albuminuria is modifiable. Reductions in albumin excretion, achieved through better blood pressure control, better glucose control, weight loss and appropriate medical treatment decided by your doctor, are associated with better long-term kidney outcomes. That is unusual and valuable: a marker that both predicts trouble and responds to action. It means stage 1 is one of the few points in this disease where the trajectory can genuinely be bent. General measures that support kidney health are covered in how to protect kidney function and prevent creatinine rising.

The three-month rule and why it is not a formality

Chronic means lasting. The three-month requirement exists to separate persistent kidney disease from the many transient abnormalities that resolve on their own, and skipping it produces false diagnoses.

Plenty of things cause a one-off abnormal urine albumin. A urinary tract infection. A fever. A hard gym session the day before. Very high blood sugar. Heart failure. Even prolonged standing in some people. Each can push an ACR into the A2 range in someone whose kidneys are entirely normal, and each resolves without any intervention.

If you have been told you have stage 1 CKD on the strength of a single urine test, that is a reasonable thing to query. Not because your doctor is wrong, but because the confirmation step matters and is sometimes compressed. A diagnosis of chronic kidney disease can affect insurance applications and follows you through your records for decades. It should be right.

The same logic applies to blood results. Creatinine fluctuates for all sorts of reasons that have nothing to do with kidney disease, which is covered in how much creatinine levels fluctuate and, for the causes of genuine elevation, what causes high creatinine. Single results are weak evidence in both directions.

Stage 1 versus stage 2: a smaller difference than it sounds

Stage 2 has the same requirement for a damage marker. The only difference is that eGFR has fallen to somewhere between 60 and 89, which is described as mildly reduced.

The wording sounds ominous and mostly is not. eGFR declines naturally with age at roughly 0.8 to 1 mL/min per year after about 40, so an eGFR in the 70s is extremely common in healthy people in their sixties and seventies. Without a damage marker, that is not kidney disease at all; it is a normal aging kidney. With a damage marker, it is stage 2, and the practical management is very close to stage 1.

Moving from stage 1 to stage 2 on a single test is also not the event it appears to be. eGFR has real measurement variability, in the region of five to ten percent between tests, so a value of 92 followed by a value of 87 is well within the noise. What matters is the trend across several years, not the crossing of a round number. A drop of more than about five points sustained across repeated tests is worth attention. A single dip is usually not.

The stages that genuinely change management sit further down. Stage 3 brings in monitoring for anemia, bone chemistry and other complications, and stage 4 brings planning conversations. Those are covered separately in our pieces on stage 3 creatinine levels and the creatinine levels associated with kidney failure. At stage 1 none of that applies.

What stage 1 means for your future

Here is the part most people actually want answered, and the honest version is more reassuring than the phrase chronic kidney disease suggests.

Most people with stage 1 never reach kidney failure. The large majority stay stable for decades or improve. Progression through the stages is not a conveyor belt, and stage 1 is not an early position on a fixed path to dialysis. Across the whole population of people with early CKD, far more die of something unrelated, usually cardiovascular, than ever progress to needing renal replacement. That is a grim way to put a reassuring fact, but it is the accurate one.

What determines which way it goes is mostly the cause and how well it is controlled.

The variable that predicts progression best is not your current eGFR, since at stage 1 it is normal by definition. It is the albuminuria level and its direction of travel, together with blood pressure control. An ACR falling from 90 to 40 over two years is a genuinely good sign. One rising from 40 to 150 over the same period is the thing to act on, and acting at that point is far more effective than acting once creatinine has started to climb.

What should actually happen at stage 1

The management of stage 1 is unglamorous and largely consists of five things done consistently.

Notice what is not on the list. There is no kidney-specific diet at stage 1. Protein restriction is not indicated when filtration is normal. Potassium and phosphate restrictions belong to much later stages and can cause harm if applied unnecessarily. Fluid restriction is emphatically not indicated; if anything, staying properly hydrated is helpful. The advice that circulates online about renal diets is aimed at people with far more advanced disease, and applying it at stage 1 usually means eating worse for no benefit.

The general lifestyle picture is the same one that protects your heart, which is not a coincidence given how closely the two systems track. Stop smoking. Keep weight in a healthy range. Stay active. Keep salt intake moderate, which supports blood pressure control. Drink enough water without forcing large volumes. There is more detail in how to lower creatinine levels, though at stage 1 the creatinine is normal and the aim is keeping it that way rather than bringing it down.

Being told you have kidney disease while feeling completely well

This deserves its own section because it is the part that clinical guidance handles worst.

You feel fine. You have no symptoms. Every number on your blood test is inside the normal range, including the one that supposedly measures kidney function. And you have been given a diagnosis with the words chronic, kidney and disease in it. The gap between how you feel and what you have been told is wide, and it produces a specific kind of anxiety that is difficult to talk anyone out of, because the reassurance sounds like a contradiction of the diagnosis.

A few things genuinely help. The first is understanding that the word stage is doing damage here. In most of medicine, staging comes from oncology, where stage 1 means early cancer that will progress if untreated. Kidney staging borrowed the vocabulary and not the meaning. Stage 1 CKD is not early kidney failure. It is a description of a current state, and the majority of people who have it stay where they are.

The second is knowing that the diagnosis is deliberately set at a sensitive threshold. It is designed to catch people early, which necessarily means it catches a lot of people whose disease will never do anything. That is a feature of screening rather than a flaw, but it does mean the label is applied to a very wide range of situations, from trivial to serious. Where you sit in that range is a question your doctor can answer specifically, and it is far more informative than the stage.

The third is having something to do. Anxiety about a health label is much worse when it feels passive. At stage 1 there are real levers: blood pressure, glucose, weight, smoking, avoiding habitual anti-inflammatories, turning up for the annual test. None is dramatic and all of them shift the odds. People who understand what they are monitoring and why tend to find the diagnosis much easier to carry.

One practical note on insurance and employment: a recorded diagnosis of chronic kidney disease can appear in medical reports for life insurance and some occupational assessments, even at stage 1. This is another reason the confirmation step matters, and a reasonable thing to discuss with your doctor if a single abnormal test led to the label.

Things people get told about stage 1 that are not true

A handful of claims circulate widely enough to be worth correcting directly.

The related question of whether the number itself can be pushed down safely comes up constantly, and is worth reading separately in what a high creatinine actually means and when a creatinine result is genuinely worth worrying about. At stage 1 neither applies to you yet, which is the good news buried in the diagnosis.

Questions worth asking at your next appointment

Stage 1 appointments are short and it is easy to leave with the label and none of the detail that makes it meaningful. These are the questions that produce useful answers.

Bring your previous results if you have them. Trends are the entire game at this stage, and a doctor seeing three years of ACR values can tell you far more than one seeing today’s number alone. If you keep your own record, note the units each time, since the mg/g and mg/mmol confusion accounts for a surprising number of unnecessary scares.

What monitoring actually involves, year to year

For most people at stage 1, an annual review takes about ten minutes and involves two tests.

Everything else that people associate with kidney disease, such as hemoglobin, calcium, phosphate and parathyroid hormone monitoring, belongs to stage 3 and beyond. At stage 1 those tests are not routinely needed, and their absence from your review is correct rather than an oversight.

If you want to sanity-check your own eGFR between appointments, the creatinine clearance calculator gives you an estimate from your creatinine, age, sex and weight. It is not a substitute for the laboratory’s own eGFR, which uses a different equation, but it is a reasonable cross-check and it makes the relationship between the numbers concrete. The background on how the two differ is in what creatinine clearance means and how GFR is calculated from creatinine. The National Kidney Foundation also has a clear explainer on eGFR and what the ranges mean.

Symptoms that need attention regardless of your stage

Stage 1 itself causes no symptoms. That makes it worth knowing which symptoms are never explained by stage 1 and should be assessed promptly, because if they appear, something else is happening.

Illness with vomiting or diarrhea deserves a particular mention. Dehydration during acute illness is one of the more common routes to an unexpected drop in kidney function, and several ordinary medications behave differently when you are dry. Many practices have specific advice for what to do with regular medicines during a vomiting illness. Ask your own doctor or pharmacist what applies to you, and do not adjust anything on your own initiative.

Frequently asked questions